NCT00037544View on ClinicalTrials.gov

Study Evaluating ReFacto AF in Severe Hemophilia A

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions

Hemophilia A

Interventions

DRUG

ReFacto AF

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00037544 - Study Evaluating ReFacto AF in Severe Hemophilia A | Biotech Hunter | Biotech Hunter